Grosgogeat Y
Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:49-54.
Ischemic heart disease is a major public health problem in all countries with high living standards. In France, in 1978, myocardial infarction was responsible for a quarter of cardiovascular deaths, which themselves represent 37% of all deaths. The economic burden of coronary artery disease may be assessed quantitatively in terms of hospital admission to departments of cardiology and cardiac surgery, and qualitatively, in terms of incapacity or invalidity, the socio-professional effects of which are considerable. This naturally incites cardiologists to examine closely the true context of their investigatory procedures, their comparative value and their ethical and financial consequences. Several factors must be taken into consideration: --increasing the availability of new techniques, which necessitates their critical evaluations; --specialisation within the medical team may affect relationships; --the efficacity and increasing risks of diagnostic evaluation and medical and surgical therapy. The evolution of cardiac treatment may be used to assess decisions taken during hospital admissions and so help avoid duplication of complementary investigations, unnecessary hospital admission and investigations. This research based on audits should help the cardiologist realise the true contribution of non-invasive investigations in the diagnosis of cardiac disease. By underlying the importance of his attitude, adapted to the patients' real needs, the cardiologist will abandon an often too subjective appreciation in favour of better management from the scientific, ethical and eventually, economical points of view. However, this type of assessment has its limits. It would be a worthless task to make all medical procedures generally available to all cardiologists in France. Local, epidemiological or scientific specificities would be disregarded. Similarly, excessive normalisation is incompatible with clinical research which implies high level, costly, scientific activity. But is this not one of the fundamental objectives of teaching hospitals?
在所有生活水平较高的国家,缺血性心脏病都是一个重大的公共卫生问题。1978年在法国,心肌梗死导致了四分之一的心血管疾病死亡,而心血管疾病死亡占所有死亡人数的37%。冠状动脉疾病的经济负担可以从心脏病学和心脏外科科室的住院情况进行定量评估,也可以从丧失工作能力或残疾方面进行定性评估,其对社会职业的影响相当大。这自然促使心脏病专家仔细审视他们研究程序的真实背景、比较价值以及伦理和经济后果。必须考虑几个因素:——新技术的可及性增加,这就需要对其进行批判性评估;——医疗团队内部的专业化可能会影响人际关系;——诊断评估以及内科和外科治疗的有效性和风险增加。心脏治疗的发展可用于评估住院期间做出的决策,从而有助于避免重复进行补充检查、不必要的住院和检查。这项基于审核的研究应有助于心脏病专家认识到无创检查在心脏病诊断中的真正作用。通过强调适应患者实际需求的态度的重要性,心脏病专家将摒弃通常过于主观的评估方式,转而从科学、伦理以及最终的经济角度进行更好的管理。然而,这种评估类型有其局限性。要让法国所有心脏病专家都普遍采用所有医疗程序是一项毫无价值的任务。地方、流行病学或科学的特殊性将被忽视。同样,过度标准化与临床研究不相容,临床研究意味着高水平、高成本的科学活动。但这难道不是教学医院的基本目标之一吗?